LGND

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is a biopharmaceutical company founded in 1987 and headquartered in Emeryville, California. The company went public in 1992 and has undergone significant strategic transformation over the past few years. Originally operating as a traditional biotechnology company with internal drug development programs, Ligand has evolved into a focused royalty and investment company that partners with pharmaceutical companies to develop and commercialize medicines. The company has streamlined its operations dramatically, reducing its workforce from 170 employees to approximately 35 while maintaining a lean, infrastructure-light business model centered on generating royalties from pharmaceutical products and investing in late-stage drug development opportunities.